RT @TumorBoardTues
#SABCS22 came & went, but the exciting info for #BreastCancer is continuing to come your way via #TumorBoardTuesday!!

@jane_meisel @quirogad
📅Tues, 12/20/22 at🕗8PM ET
✅polls
⚖️in & bring citations🧾
🔁Retweet & tag 🩺colleagues
🏆Earn your🆓CME & MOC http://integrityce.com/tbt

RT @cspramesh
Yet another impactful study from @TataMemorial evaluating the impact of yoga on quality of life in women with breast cancer. Simple intervention, and bringing much-needed evidence to AYUSH medicine. #SABCS22 @nitaSnair @nishusgoel22

RT @LauBuisseret@twitter.com

Such a great #SABCS22 meeting to promote #WomenHealth through our mission to fight #BreastCancer but let's not forget that #womenHealth is also access to safe and legal abortion #womenrights 🫤

🐦🔗: https://twitter.com/LauBuisseret/status/1601638083077689344

RT @BIGagainstBC@twitter.com

#POSITIVE trial showed that temporary interruption of adj ET for women with BC to attempt pregnancy does not impact short-term disease outcomes; most pts had at least one pregnancy. Long-term follow-up is planned. @etop_ibcsg@twitter.com @ALLIANCE_org@twitter.com #reproductivehealth @OncoAlert@twitter.com #SABCS22

🐦🔗: https://twitter.com/BIGagainstBC/status/1601263530879098880

AZ's Enhertu scores head-to-head win vs. Roche's Kadcyla in breast cancer — Pfizer posts meme hitting back at vaccine disinformation — Setting the stage for ASH2022 -- See more on our front page news http://bit.ly/w28kSd #astrazeneca #breastcancer #sabcs22 #roche #pfizer #vaccines #disinformation #meme #socialmedia #covid19 #covid #ash2022 #pharma #pharmanews #biotech #biotechnology #biopharma #cafepharma

RT @OncoAlert@twitter.com

The @OncoAlert@twitter.com 🚨 #SABCS22 How it Started

Dec 10, 2019
OncoAlert SABCS19 Kick off at the @MengerHotel@twitter.com
@ErikaHamilton9@twitter.com @NicoleKuderer@twitter.com @coffeemommy@twitter.com @itsnot_pink@twitter.com @aftimosp@twitter.com @matteolambe@twitter.com @DrSGraff@twitter.com @E_de_Azambuja@twitter.com @MarianaBrandao0@twitter.com @weoncologists@twitter.com

🐦🔗: https://twitter.com/OncoAlert/status/1600883372586213378

RT @OncoAlert@twitter.com

Dear Friends at #SABCS22 🚨
A reminder not to miss The People’s Choice Ed Session:
Advances in Pregnancy🤰Associated #BreastCancer
Tomorrow Friday 12/09/03 3PM-5PM
Drs.Siziopikou, @AnnPartridgeMD@twitter.com 🇺🇸from @DFCI_BreastOnc@twitter.com @DanaFarber@twitter.com & @matteolambe@twitter.com 🇮🇹 from @UniGenova@twitter.com @SanMartino_Ge@twitter.com

🐦🔗: https://twitter.com/OncoAlert/status/1600905799198384128

RT @OncoAlert@twitter.com

A Great DAY2⃣at #SABCS22 ‼️
Thank you @SABCSSanAntonio@twitter.com & Thanks Colleagues Worldwide🗺️

45.6M Impressions
6,5K Tweets
@OncoAlert@twitter.com 🚨faculty9⃣0⃣%of TOP🔟influences
3⃣of them Patient Advocates🙌

WE ARE ALL #Oncoalert 🌐
Best,
@weoncologists@twitter.com

🐦🔗: https://twitter.com/OncoAlert/status/1600872263170998273

RT @Fimereli_Danai@twitter.com

Poster Spotlight Discussion PD4-01 on the excellent work of @Wang_Xiaoxia0@twitter.com and @c_sotiriou@twitter.com lab:
Spatial transcriptomics reveals a substantial heterogeneity in TNBC tumor and stroma compartments woth potential clinical implications
@JulesBordet@twitter.com #SABCS22

🐦🔗: https://twitter.com/Fimereli_Danai/status/1600490604357685248

RT @LauBuisseret@twitter.com

@DMBranco@twitter.com from @JulesBordet@twitter.com presenting the results of a systematic review on the pronostic role of Ki67 after neo-adj CT ➡️ Ki67 is a valuable bio marker in women with ER+ early #BreastCancer #SABCS22 @E_de_Azambuja@twitter.com @aftimosp@twitter.com

🐦🔗: https://twitter.com/LauBuisseret/status/1600275858102419456